Tandem Diabetes Care, Inc. (TNDM), an insulin delivery and diabetes technology company, has reported strong sales results for the first quarter of 2025 and issued guidance for the full year.
The company develops insulin pumps and diabetes management technologies, including the Tandem Mobi system and Control-IQ Technology. The company's products are aimed at improving the quality of life for people with diabetes by offering advanced, user-friendly solutions for insulin delivery.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com